Patents Examined by Stephen M. Kapner
  • Patent number: 4556737
    Abstract: This invention provides novel sulfonium compounds, processes for the preparation of the sulfonium compounds, and pharmacological composition containing the sulfonium compound. The compounds of this invention are useful for treating allergy.
    Type: Grant
    Filed: February 27, 1984
    Date of Patent: December 3, 1985
    Assignee: Taiho Pharmaceutical Company Limited
    Inventors: Akihide Koda, Mikio Hori, Naosuke Matsuura, Mitsugi Yasumoto, Ichiro Yamawaki, Shuichi Ueda, Yukio Tada
  • Patent number: 4556656
    Abstract: Isochromans, isothiochromans, 2-benzoxepins, and 2-benzothiepins are described. The compounds possess hypotensive and anti-psychotic properties; methods and compositions using them are described.
    Type: Grant
    Filed: April 4, 1979
    Date of Patent: December 3, 1985
    Assignee: The Upjohn Company
    Inventor: John M. McCall
  • Patent number: 4555572
    Abstract: Pyrazolo[3,4,5-kl]acridines are described as antibacterial agents and antitumor agents as well as pharmaceutical compositions and methods for their preparation.
    Type: Grant
    Filed: June 15, 1984
    Date of Patent: November 26, 1985
    Assignee: Warner-Lambert Company
    Inventor: David B. Capps
  • Patent number: 4554276
    Abstract: Novel 2-amino-5-hydroxy-4-methylpyrimidines and substituted amino derivatives thereof useful as inhibitors of leukotriene synthesis for the treatment of pulmonary, inflammatory and cardiovascular diseases, cancer and psoriasis. In addition these compounds are cytoprotective and therefore useful in the treatment of peptic ulcers. A process for the preparation of such active compounds by ring rearrangement of 2-amino-5-acetyloxazole, pharmaceutical compositions containing the novel active compounds and compositions containing these compounds in combination with other anti-inflammatory agents or gastric anti-secretory agents.
    Type: Grant
    Filed: October 3, 1983
    Date of Patent: November 19, 1985
    Assignee: Pfizer Inc.
    Inventor: John L. LaMattina
  • Patent number: 4554110
    Abstract: An improved process for the preparation of aromatic carbonates selected from aliphatic aromatic carbonates, diaromatic carbonates, and mixtures thereof comprising reacting a phenolic compound with a dialiphatic carbonate or an aliphatic aromatic carbonate in the presence of a catalytic amount of at least one catalyst selected from polymeric tin compounds containing recurring structural units represented by the general formula ##STR1## wherein: R is selected from monovalent hydrocarbon radicals; andR.sup.1 is selected from monovalent hydrocarbon radicals.
    Type: Grant
    Filed: December 27, 1983
    Date of Patent: November 19, 1985
    Assignee: General Electric Company
    Inventor: Victor Mark
  • Patent number: 4552704
    Abstract: An improved process for the preparation of aromatic carbonates selected from aliphatic aromatic carbonates, diaromatic carbonates, and mixtures thereof comprising reacting at least one phenolic compound with at least one dialiphatic carbonate or at least one aliphatic aromatic carbonate in the presence of a catalytic amount of at least one transesterification catalyst represented by the general formula ##STR1## wherein: X is selected from Sn and Ti; andR is selected from monovalent hydrocarbon radicalsand monovalent hydrocarbonoxy radicals.
    Type: Grant
    Filed: December 27, 1983
    Date of Patent: November 12, 1985
    Assignee: General Electric Company
    Inventor: Victor Mark
  • Patent number: 4551529
    Abstract: A purified isolate of an actinomycete identified as ATCC 39364 is capable of producing the antimicrobial/antitumor compound 2-amino-1,9-dihydro-6H-purine-6-one-7-oxide, commonly known as guanine-N.sup.7 -oxide.Guanine-N.sup.7 -oxide is produced by cultivating isolate ATCC 39364 under aerobic conditions in a culture medium containing assimilable sources of carbon and nitrogen until a substantial amount of the compound is produced and thereafter isolating the compound.The antibiotic/antitumor compound guanine-N.sup.7 -oxide and pharmaceutical compositions comprising this compound or one of its pharmaceutically acceptable salts together with a pharmaceutically acceptable carrier are also disclosed as is a method of treating microbial infections in a mammal or of treating tumors in a mammal.
    Type: Grant
    Filed: October 6, 1983
    Date of Patent: November 5, 1985
    Assignee: Warner-Lambert Company
    Inventors: Donald L. Kern, Gerard C. Hokanson, James C. French
  • Patent number: 4540698
    Abstract: Disclosed herein are a novel compound, 5-methylthiopyrimidine derivative, notably that represented by the following general formula: ##STR1## wherein X means an oxygen or sulfur atom and R.sup.2 denotes a methyl, allyl or propargyl group, its preparation process and an agricultural and horticultural fungicide containing same as an active ingredient. The above compound exhibits outstanding control effects against plant diseases, especially, late blight of potatoes and the like and downly mildew. It permits preparation of an ideal agricultural and horticultural fungicide owing to its very low toxicity against mammal and fish and its no phytotoxicity.
    Type: Grant
    Filed: January 14, 1983
    Date of Patent: September 10, 1985
    Assignee: Mitsui Toatsu Chemicals, Incorporated
    Inventors: Katsutoshi Ishikawa, Hitoshi Shimotori, Noboru Iida, Kazuo Akihiro, Shuji Ozawa
  • Patent number: 4536504
    Abstract: Novel compounds of the formula: ##STR1## wherein R.sup.1 is lower alkyl; R.sup.2 is hydrogen or lower alkyl, which are produced by reacting a compound of the formula: ##STR2## wherein R.sup.3 is hydrocarbon residue, with a compound of the formula: ##STR3## The novel compounds have antiviral and antibacterial activity, and are useful to prolong the life span of tumor-bearing warm-blooded animals.
    Type: Grant
    Filed: July 13, 1983
    Date of Patent: August 20, 1985
    Assignee: Takeda Chemical Industries, Ltd.
    Inventor: Tetsuya Okutani